Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Data mining in pharmacovigilance: the need for a balanced perspective.

Manfred Hauben1, Vaishali Patadia, Charles Gerrits

  • 1Risk Management Strategy, Pfizer Inc, New York, New York 10017, USA.

Drug Safety
|September 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same author

Verbal Expressions of Probability in Pharmacovigilance: Most Likely Too Ambiguous.

Clinical therapeutics·2026
Same author

A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.

Drug safety·2026
Same author

It's Your Right - implementation and outcomes of a co-designed national Australian hepatitis C health promotion campaign.

The International journal on drug policy·2026
Same author

Promoting the Implementation of Co-Produced Cochrane Evidence: An Exploratory Study of Improving Partnering With Consumers.

Cochrane evidence synthesis and methods·2026
Same author

Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group.

Drug safety·2026

Data mining offers promising pharmacovigilance tools but requires careful validation and understanding of limitations. Clinical judgment remains crucial, regardless of algorithm complexity, for safe application.

Area of Science:

  • Pharmacovigilance
  • Data Mining
  • Drug Safety

Background:

  • Data mining is increasingly utilized for pharmacovigilance, yet several misconceptions persist regarding its application and interpretation.
  • Common misunderstandings include the validation status of algorithms, objectivity in screening data, the superiority of complex models, and the scope of applications beyond hypothesis generation.

Purpose of the Study:

  • To address and clarify four key areas of misunderstanding in the application of data mining for pharmacovigilance.
  • To provide a balanced perspective on the capabilities and limitations of data mining algorithms in drug safety surveillance.

Main Methods:

  • Discussion and critical analysis of common viewpoints on data mining in pharmacovigilance.
  • Review of validation challenges, subjectivity, model complexity, and application scope.

Related Experiment Videos

Main Results:

  • Data mining algorithms have undergone validation, but a lack of gold standards and situational dependencies complicate interpretation.
  • The subjective nature of data mining is often underestimated, and simpler models can be enhanced with clinical shrinkage.
  • Applications beyond hypothesis generation are risky due to data limitations, potentially leading to overconfidence.

Conclusions:

  • Contemporary data mining algorithms are valuable pharmacovigilance tools, but their verification level must match the claimed applications.
  • Emphasizes the critical importance of considering data limitations, clinical judgment, and context alongside statistical findings.